Evolution of the Average Target: VTEX

Evolution of the Target Price: VTEX

Changes in Analyst Recommendations: VTEX

3b8f89d6500d16ed55d8c86e42567e5.XpY_TdMLbjXOM88fhMIro7srKZEW34_4lBoTUdRnSKI.b8BrHZt9OXqaZKtJtIwclNZfH9lPjPuT1lRBMLUqP-Q_zG4fv2dWZZRf-w~31abf7319097d36cdef1ad9fef4a9263
01-15 VTEX Shares Fall After UBS Downgrade MT
01-15 UBS Downgrades VTEX to Neutral From Buy, Adjusts Price Target to $4 From $8 MT
16/10/25 Goldman Sachs Initiates Coverage on VTEX With Buy Rating, $5.30 Price Target MT
17/09/25 VTEX Shares Rise After Jefferies Upgrade MT
17/09/25 Jefferies Upgrades VTEX to Buy From Hold, Price Target is $6.50 MT
08/08/25 JPMorgan Downgrades VTEX to Neutral From Overweight, Trims Price Target to $6 From $7.50 MT
07/08/25 VTEX Q2 revenue misses estimates RE
22/05/25 Jefferies Initiates VTEX at Hold With $7.30 Price Target MT
20/12/24 UBS Adjusts VTEX Price Target to $11 From $12.50, Maintains Buy Rating MT
06/12/24 Citigroup Initiates VTEX at Neutral With $6.70 Price Target MT
12/08/24 UBS Adjusts Price Target on VTEX to $12.50 From $12, Maintains Buy Rating MT
14/05/24 VTEX Shares Jump After Upgrade From J.P. Morgan MT
14/05/24 JPMorgan Upgrades VTEX to Overweight From Neutral, Price Target is $9 MT
25/03/24 UBS Adjusts VTEX Price Target to $12 From $8.50, Maintains Buy Rating MT
05/01/24 Morgan Stanley Upgrades VTEX to Overweight From Equalweight, Adjusts Price Target Price Target to $8 From $5.50 MT
20/11/23 UBS Adjusts VTEX Price Target to $8.50 From $7.50 Maintains Buy Rating MT
08/11/23 Piper Sandler Adjusts Price Target on VTEX to $7 From $6, Maintains Overweight Rating MT
23/08/23 UBS Upgrades VTEX to Buy From Neutral, Adjusts Price Target to $7.50 From $4.70 MT
09/08/23 Piper Sandler Adjusts Price Target on VTEX to $6 From $5, Maintains Overweight Rating MT
10/05/23 Itau BBA Upgrades VTEX to Outperform From Market Perform With $6 Price Target MT
09/03/23 DA Davidson Initiates VTEX at Buy With $5 Price Target MT
20/12/22 Piper Sandler Cuts Price Target on VTEX to $5 From $6, Reiterates Overweight Rating MT
19/12/22 Morgan Stanley Downgrades VTEX to Equalweight From Overweight, Adjusts Price Target to $5 From $7 MT
02/11/22 UBS Adjusts VTEX Price Target to $4.70 From $4.30, Maintains Neutral Rating MT
20/10/22 UBS Initiates VTEX at Neutral with $4.30 Price Target MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+66.02%
+43.67%
+43.55%
+9.19%
+0.11%
+23.46%
+1.38%
+69.39%
+31.81%
-3.22%
Average +28.54%
Weighted average by Cap. +39.79%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
3.620USD
Average target price
6.010USD
Spread / Average Target
+66.02%
High Price Target
12.00USD
Spread / Highest target
+231.49%
Low Price Target
4.100USD
Spread / Lowest Target
+13.26%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
Goldman Sachs
Jefferies & Co.
JPMorgan Chase
Citigroup
Morgan Stanley
Piper Sandler
Itau BBA
DA Davidson
BofA Securities
KeyBanc Capital Markets
Credit Suisse
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
3.620USD
Average target price
6.010USD
Spread / Average Target
+66.02%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!